
...
By Eli Lippman
Contributing Entertainment Editor
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
In a move that blurs the line between science fiction and reality, Colossal Biosciences, the pioneering de-extinction company backed by countless celebs, has secured $200 million in Series C funding. This brings their total investment to nearly half a billion dollars since their inception in 2021, solidifying their position at the forefront of a revolutionary field.
Co-founded by geneticist George Church and billionaire tech entrepreneur Ben Lamm, Colossal has achieved "decacorn" status in just three years, boasting a valuation exceeding $10 billion. This rise places them among an elite group of startups worldwide and shows the growing interest in the once-fantastical concept of de-extinction.

...
Read More on Celebrity News
The company's ambitious goal is to resurrect extinct species like the woolly mammoth, the dodo, and the Tasmanian tiger. By leveraging cutting-edge genetic engineering technologies, Colossal aims to restore these creatures to their rightful place in the ecosystem, potentially mitigating the devastating effects of biodiversity loss.
Colossal's impressive investor list includes prominent figures like Dodgers owner and Guggenheim CEO Mark Walter, Hollywood heavyweight and legendary tech investor Thomas Tull, and a constellation of other billionaires ranging from Paul Tudor Jones to Jenny Just. Notably, the company has also garnered support from high-profile celebrities such as Tom Brady, Peter Jackson, Peter Jackson, Fran Walsh, Tiger Woods, Tony Robbins, Paris Hilton, and the Hemsworth brothers, further amplifying their visibility and influence.
"The continued support by the investment community and the broader markets has been truly amazing," says Lamm to Newsweek. "We are excited to expand our efforts on new species and even more technology development."
While the prospect of bringing back extinct animals raises ethical and logistical questions, Colossal's work represents a potential paradigm shift in conservation efforts. As extinction rates climb, the company's pursuit of de-extinction technologies offers a glimmer of hope for restoring lost biodiversity and rebuilding degraded ecosystems.
Although Colossal is not focused on bringing back dinosaurs, Lamm suggests that the prehistoric past may be closer than we think. With their sights set on a future where woolly mammoths roam the tundra once again, Colossal Biosciences is poised to redefine the boundaries of what's possible in science and conservation.
View 0 Comments
Submit Correction
View Editorial & AI Guidelines